tm
Seeing Is Believing
tm
Seeing Is Believing
Alder BioPharmaceuticals's activity chart (see below) currently has 61 price targets and 52 ratings on display.
Analysts average stock forecasts to be materialized ratio is 9.21% with an average time for these price targets to be met of 44.37 days.
Most recent stock forecast was given by from LEERINK on 17-Sep-2019. First documented stock forecast 02-Jun-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-May-2019
$20
$1.12 (5.93%)
$21
6 years 11 months 29 days ago
(17-Sep-2019)
0/2 (0%)
$1.3 (6.95%)
Buy Since 27-Jun-2018
$28
6 years 11 months 29 days ago
(17-Sep-2019)
0/2 (0%)
$17.22 (159.74%)
Hold Since 16-Sep-2019
$18
$-0.88 (-4.66%)
$19
6 years 11 months 30 days ago
(16-Sep-2019)
0/2 (0%)
$-0.5 (-2.70%)
Buy Since 31-Jan-2018
$20
$1.12 (5.93%)
$20
6 years 11 months 30 days ago
(16-Sep-2019)
0/3 (0%)
$1.5 (8.11%)
Buy Since 06-Aug-2015
$41
7 years 3 months 18 days ago
(28-May-2019)
0/4 (0%)
$12.28 (42.76%)
What is ALDR (Alder BioPharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on ALDR (Alder BioPharmaceuticals)?
Which analyst has the most public recommendations on ALDR (Alder BioPharmaceuticals)?
Which analyst is the currently most bullish on ALDR (Alder BioPharmaceuticals)?
Which analyst is the currently most reserved on ALDR (Alder BioPharmaceuticals)?
